A single arm open label interventional study to evaluate the efficacy of mutra sangrahaneeya mahakashaya in childhood nephrotic syndrome w.s.r. to ojo vyapada. - NI

O SPONSER0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

研究概览

暂无简介。

•1.Diagnosed cases of Minimal Change steroid dependent Nephrotic Syndrome with less than three relapses so far.
•2.Diagnosed cases of Minimal Change Nephrotic Syndrome with less than nephrotic range of proteinurea (not more than 3gm/24 hr protein loss)
•3.Diagnosed cases of Minimal Change Nephrotic Syndrome without any documented adverse effects of steroid therapy.
•4.Diagnosed cases of Minimal Change Nephrotic Syndrome with chronicity of less than 1 year.

•1.Child with more than three episodes of recurrences requiring higher doses of steroid and with chronicity of more than one year and more than three relapses so far.
•2.Children with gross Congenital Anomalies, urogenital anomalies
•3.Children with Genetic Nephrotic Syndrome and involvement of kidney parenchyma
•4.Children with Secondary Glomerulonephritis (eg. Post infectious Glomerulonephritis, SLE, Diabetic neuropathy, Henoch-Schonlein Syndrome)
•5.Children of Nephrotic Syndrome with end stage disease.
•6.Children receiving immune-suppressant other than steroid like cytotoxic drugs etc. with indication of renal biopsy

发起方

O SPONSER